Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Ascend Laboratories, LLC recalls Dabigatran Etexilate Capsules

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Products
  • Dabigatran Etexilate Capsules
Where it was sold

USA Nationwide

Nationwide

Units affected
924 cartons x 12 x 6 x 10 (in blister pack)
About this recall
Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-68.